Experience Tissue Cure in Tampere on March 19th

Tissue Cure Alliance Finland (TCAF) will host a networking afternoon in Tampere in March. At the event you can experience live demonstrations, watch presentations and interact with other people. If you are interested in the field of tissue regeneration and wound care, this is the event for you! The purpose of the event is to get together, exchange knowledge and ideas.
Free snacks are offered!


Thursday March 19th 2020 at 14:00. Tribe Tampere, Pinninkatu 47, Tampere. The event will be open until 17:00.


  • Live Demonstrations: Come and see live wound measurement with CutoSense and try Bioprinting with Immuno Diagnostic!
  • Presentations: At the event you will see short presentations of TCAF members. In addition to the above, UPM Biomedicals, Askel Healthcare, Red Cross Blood Service and Åbo Akademi University will be present.
  • Networking: Most of the event will be dedicated to informal discussions and free interaction. – Free snacks: Drinks and snacks will be offered free of charge!


Please sign up for the event by sending an email to TCAF coordinator Andreas Slama, andreas.slama@tissuecure.fi as soon as possible, but no later than March 17th.


Tissue Cure Alliance Finland (TCAF) is a non-profit community for Finnish tissue regeneration and wound care companies and for research organisations. Sharing experiences and best practises is at the heart of the Alliance. In addition, the Alliance aims at promoting and marketing the products and solutions provided by its members.


The Alliance was founded in 2018 by Finnish start-up companies Askel Healthcare Oy, CutoSense Oy, Finnish Red Cross Blood Service, UPM Biomedicals and Åbo Akademi University.

For more information contact coordinator Andreas Slama, andreas.slama@tissuecure.fi or chairman Virpi Muhonen, virpi.muhonen@askelhealthcare.com or visit www.tissuecure.fi

New pharmaceutical research utilising nanobiotechnology in Finland

A new research ecosystem has been set up in Finland in which the country’s leading research organisations, together with the Finnish Red Cross Blood Service, Orion Pharma and nanotechnology SMEs, are joining forces to develop new types of nanobiotechnological solutions for the treatment and early diagnostics of severe progressive diseases.

Read more on the Finnish Red Cross Blood Service webpage: